1. Home
  2. TMCI vs SPOK Comparison

TMCI vs SPOK Comparison

Compare TMCI & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • SPOK
  • Stock Information
  • Founded
  • TMCI 2014
  • SPOK 2004
  • Country
  • TMCI United States
  • SPOK United States
  • Employees
  • TMCI N/A
  • SPOK N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SPOK Telecommunications Equipment
  • Sector
  • TMCI Health Care
  • SPOK Telecommunications
  • Exchange
  • TMCI Nasdaq
  • SPOK Nasdaq
  • Market Cap
  • TMCI 449.2M
  • SPOK 379.1M
  • IPO Year
  • TMCI 2021
  • SPOK 1992
  • Fundamental
  • Price
  • TMCI $7.33
  • SPOK $17.44
  • Analyst Decision
  • TMCI Hold
  • SPOK Hold
  • Analyst Count
  • TMCI 5
  • SPOK 1
  • Target Price
  • TMCI $8.60
  • SPOK $15.00
  • AVG Volume (30 Days)
  • TMCI 343.4K
  • SPOK 149.8K
  • Earning Date
  • TMCI 11-04-2025
  • SPOK 10-29-2025
  • Dividend Yield
  • TMCI N/A
  • SPOK 7.11%
  • EPS Growth
  • TMCI N/A
  • SPOK 10.71
  • EPS
  • TMCI N/A
  • SPOK 0.83
  • Revenue
  • TMCI $213,751,000.00
  • SPOK $140,742,000.00
  • Revenue This Year
  • TMCI $10.63
  • SPOK $2.26
  • Revenue Next Year
  • TMCI $9.44
  • SPOK $3.69
  • P/E Ratio
  • TMCI N/A
  • SPOK $21.18
  • Revenue Growth
  • TMCI 7.67
  • SPOK 1.79
  • 52 Week Low
  • TMCI $4.54
  • SPOK $13.55
  • 52 Week High
  • TMCI $10.79
  • SPOK $19.31
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 58.53
  • SPOK 42.62
  • Support Level
  • TMCI $6.93
  • SPOK $17.16
  • Resistance Level
  • TMCI $7.48
  • SPOK $17.70
  • Average True Range (ATR)
  • TMCI 0.32
  • SPOK 0.35
  • MACD
  • TMCI -0.05
  • SPOK -0.07
  • Stochastic Oscillator
  • TMCI 49.70
  • SPOK 22.61

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: